NS Pharma

NS Pharma (NSP) is a company that specializes in the development and distribution of drugs. It is also engaged in clinical studies and develops NS-018 and NS-065/NCNP-01 drug candidates for the treatment of myelofibrosis and Duchenne muscular dystrophy (DMD).